Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer.

Gastrectomy lymph nodes No. 5 and No. 6 metastasis prognosis proximal gastric cancer

Journal

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
ISSN: 1000-9604
Titre abrégé: Chin J Cancer Res
Pays: China
ID NLM: 9315242

Informations de publication

Date de publication:
Feb 2019
Historique:
entrez: 19 4 2019
pubmed: 19 4 2019
medline: 19 4 2019
Statut: ppublish

Résumé

The current surgical treatment guidelines for early proximal gastric cancer (PGC) still lack agreement. Lymphadenectomy of lymph nodes No. 5 and No. 6 is the major difference between total and proximal gastrectomy. We elucidated the appropriate surgical procedure for PGC by investigating the pathological characteristics and prognostic significance of lymph nodes No. 5 and No. 6. In total, 333 PGC patients who underwent total gastrectomy were enrolled in this study. We investigated their clinicopathological characteristics and the metastatic patterns of the lymph nodes. Patients with metastasis in lymph nodes No. 5 and No. 6 were combined into one group and we compared the difference in survival between those with and without metastasis in lymph nodes No. 5, 6 (lymph nodes No. 5 and No. 6 in any group of metastasis) for different subgroups. The metastatic rates for lymph nodes No. 5 and No. 6 in PGC were 9.91% and 16.11%, respectively. The metastatic rate for both lymph nodes No. 5, 6 was 20.42%. Multivariate analysis showed that positive metastasis in lymph node No. 4, depth of invasion, and tumor size were independently correlated with the presence of metastasis in lymph nodes No. 5, 6. When lymph node No. 4 is positive (intraoperative pathology) or tumor size ≥5 cm or T4 stage, lymphadenectomy should be performed for lymph nodes No. 5 and No. 6, and total gastrectomy is recommended.

Identifiants

pubmed: 30996575
doi: 10.21147/j.issn.1000-9604.2019.01.12
pii: cjcr-31-1-171
pmc: PMC6433591
doi:

Types de publication

Journal Article

Langues

eng

Pagination

171-177

Références

Surgery. 2005 Feb;137(2):165-71
pubmed: 15674196
Am J Surg. 2008 Oct;196(4):587-91
pubmed: 18519129
Anticancer Res. 2008 Sep-Oct;28(5B):2875-83
pubmed: 19031928
Ann Surg Oncol. 2010 Mar;17(3):829-37
pubmed: 19882188
Chin Med J (Engl). 2014;127(23):4049-54
pubmed: 25430447
Surgery. 2015 Feb;157(2):285-96
pubmed: 25532433
Surgery. 2015 Nov;158(5):1446-7
pubmed: 25892684
Eur J Surg Oncol. 2015 Jul;41(7):927-33
pubmed: 25913059
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S786-93
pubmed: 25986871
Surgery. 2015 Dec;158(6):1590-7
pubmed: 26210225
Eur J Gastroenterol Hepatol. 2016 May;28(5):493-502
pubmed: 26854795
Ann Surg. 2017 Feb;265(2):277-283
pubmed: 27280511
Chin J Cancer Res. 2017 Feb;29(1):1-10
pubmed: 28373748
Oncotarget. 2017 Jun 28;8(48):84515-84528
pubmed: 29137444
J Gastric Cancer. 2017 Dec;17(4):331-341
pubmed: 29302373
Gastric Cancer. 2018 Sep;21(5):845-852
pubmed: 29423892
Int J Cancer. 2018 Dec 1;143(11):2749-2757
pubmed: 29992560
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
World J Gastrointest Oncol. 2018 Oct 15;10(10):360-366
pubmed: 30364712
Hepatogastroenterology. 1998 Jan-Feb;45(19):281-5
pubmed: 9496527

Auteurs

Jinou Wang (J)

Department of Pathology, Shengjing Hospital of China Medical University, Shenyang 110004, China.

Pei Wu (P)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Zhenning Wang (Z)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Kai Li (K)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Baojun Huang (B)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Pengliang Wang (P)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Huimian Xu (H)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Zhi Zhu (Z)

Department of Surgical Oncology, the First Hospital of China Medical University, Shenyang 110001, China.

Classifications MeSH